PNEUMOCYSTIS JIROVECI PNEUMONIA
Clinical trials for PNEUMOCYSTIS JIROVECI PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCYSTIS JIROVECI PNEUMONIA trials appear
Sign up with your email to follow new studies for PNEUMOCYSTIS JIROVECI PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to cut deaths from 'Opportunistic' pneumonia in vulnerable patients
Disease control Not yet recruitingThis study aims to see if adding steroid medication to standard care can help people with weakened immune systems survive a severe type of pneumonia called PJP. It will enroll 240 critically ill adults who do not have HIV. Researchers will test different steroid doses to find the…
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE3 • Sponsor: Qingyuan Zhan • Aim: Disease control
Last updated Apr 02, 2026 04:12 UTC
-
Trial challenges 3-Week steroid rule for deadly pneumonia
Disease control Not yet recruitingThis study aims to find the best length of steroid treatment for adults with weakened immune systems who have a severe lung infection called PCP. It will compare stopping steroids after 10 days (if the patient has recovered enough) to the standard 21-day course. The goal is to se…
Matched conditions: PNEUMOCYSTIS JIROVECI PNEUMONIA
Phase: PHASE4 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC